The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126467403 12646740 3 F 201606 20160914 20160812 20160928 EXP GB-MHRA-ADR 23556229 GB-CIPLA LTD.-2016GB09741 CIPLA 0.00 Y 0.00000 20160928 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126467403 12646740 1 PS Epirubicin EPIRUBICIN 1 Intravenous (not otherwise specified) 126 MG, UNK U 0 126 MG INFUSION
126467403 12646740 2 SS FLUOROURACIL. FLUOROURACIL 1 Intravenous (not otherwise specified) 1008 MG, CYCLE 1/6, BY A PAXMAN COOLER U 0 1008 MG
126467403 12646740 3 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 0.9 MG, QD, CYCLE 1/6, BY A PAXMAN SCALP COOLER 6.3000002 MG U 0 .9 MG QD
126467403 12646740 4 SS Ondansetron ONDANSETRON 1 Intravenous (not otherwise specified) 8 MG, UNK U U 0 8 MG
126467403 12646740 5 SS EMEND APREPITANT 1 Oral 125 MG, QD U U 0 125 MG QD
126467403 12646740 6 SS NEULASTA PEGFILGRASTIM 1 Subcutaneous 6 MG, UNK U 0 6 MG
126467403 12646740 7 SS DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) 8 MG, QD U 0 8 MG QD
126467403 12646740 8 C METOCLOPRAMIDE. METOCLOPRAMIDE 1 Unknown UNK U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126467403 12646740 1 Product used for unknown indication
126467403 12646740 2 Product used for unknown indication
126467403 12646740 3 Product used for unknown indication
126467403 12646740 4 Product used for unknown indication
126467403 12646740 5 Product used for unknown indication
126467403 12646740 6 Product used for unknown indication
126467403 12646740 7 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126467403 12646740 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126467403 12646740 Alopecia
126467403 12646740 Body temperature abnormal
126467403 12646740 Cough
126467403 12646740 Diarrhoea
126467403 12646740 Dyspnoea
126467403 12646740 Ear pain
126467403 12646740 Eating disorder
126467403 12646740 Fatigue
126467403 12646740 Feeling abnormal
126467403 12646740 Glossodynia
126467403 12646740 Headache
126467403 12646740 Hypophagia
126467403 12646740 Intercepted drug administration error
126467403 12646740 Lethargy
126467403 12646740 Lower respiratory tract infection
126467403 12646740 Malaise
126467403 12646740 Nausea
126467403 12646740 Odynophagia
126467403 12646740 Oral pain
126467403 12646740 Oropharyngeal pain
126467403 12646740 Pharyngeal erythema
126467403 12646740 Productive cough
126467403 12646740 Sputum discoloured
126467403 12646740 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126467403 12646740 1 20160608 0
126467403 12646740 2 20160608 0
126467403 12646740 3 20160608 0